Decreased cisplatin-induced nausea and vomiting with chronic alcohol ingestion

scientific article published on 01 September 1983

Decreased cisplatin-induced nausea and vomiting with chronic alcohol ingestion is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1056/NEJM198309293091317
P698PubMed publication ID6684209

P2093author name stringBell R
Sullivan JR
Leyden MJ
P433issue13
P407language of work or nameEnglishQ1860
P304page(s)796
P577publication date1983-09-01
P1433published inThe New England Journal of MedicineQ582728
P1476titleDecreased cisplatin-induced nausea and vomiting with chronic alcohol ingestion
P478volume309

Reverse relations

cites work (P2860)
Q417226605-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy
Q42528919A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapy
Q48035092Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy in the SENRI trial: analysis of risk factors for vomiting and nausea
Q34582576Comparison between the antiemetic effects of palonosetron and granisetron in breast cancer patients treated with anthracycline-based regimens
Q38894275Controlling chemotherapy-induced nausea requires further improvement: symptom experience and risk factors among Korean patients.
Q70785527Dexamethasone improves the efficacy of granisetron in the first 24 h following high-dose cisplatin chemotherapy
Q91944817Expert Consensus on Effective Management of Chemotherapy-Induced Nausea and Vomiting: An Indian Perspective
Q47572599Genetic risk factors for chemotherapy-induced nausea and vomiting in patients with cancer receiving cisplatin-based chemotherapy
Q48218900Influence of ABCB1 and ABCG2 polymorphisms on the antiemetic efficacy in patients with cancer receiving cisplatin-based chemotherapy: a TRIPLE pharmacogenomics study
Q36564254Japanese Society of Clinical Oncology clinical practice guidelines 2010 for antiemesis in oncology: executive summary
Q40815803Long-term prognosis in primary hyperoxaluria type II (L-glyceric aciduria).
Q40740167Methodological issues in antiemetic studies

Search more.